急性心肌梗死患者静脉注射茴香酰化纤溶酶原链激酶激活剂复合物治疗并发血管炎
Vasculitis complicating treatment with intravenous anisoylated plasminogen streptokinase activator complex in acute myocardial infarction.
作者信息
Bucknall C, Darley C, Flax J, Vincent R, Chamberlain D
机构信息
Department of Cardiology, Royal Sussex County Hospital, Brighton.
出版信息
Br Heart J. 1988 Jan;59(1):9-11. doi: 10.1136/hrt.59.1.9.
Abstract
Vasculitis developed in six of 253 patients treated with intravenous anisoylated plasminogen streptokinase activator complex (APSAC) after acute myocardial infarction. All patients recovered spontaneously with no evidence of renal impairment and no long term sequelae. Although leucocytoclastic vasculitis and serum sickness have been reported after streptokinase treatment, such allergic reactions have not been described as a complication of other thrombolytic agents.
摘要
253例急性心肌梗死后接受静脉注射茴香酰化纤溶酶原链激酶激活剂复合物（APSAC）治疗的患者中有6例发生了血管炎。所有患者均自发康复，没有肾功能损害的迹象，也没有长期后遗症。虽然链激酶治疗后曾有白细胞破碎性血管炎和血清病的报道，但这种过敏反应尚未被描述为其他溶栓药物的并发症。
相似文献
1
Vasculitis complicating treatment with intravenous anisoylated plasminogen streptokinase activator complex in acute myocardial infarction.急性心肌梗死患者静脉注射茴香酰化纤溶酶原链激酶激活剂复合物治疗并发血管炎
Br Heart J. 1988 Jan;59(1):9-11. doi: 10.1136/hrt.59.1.9.
2
Vasculitis complicating treatment with intravenous anisoylated plasminogen streptokinase activator complex in acute myocardial infarction.急性心肌梗死患者静脉注射氨甲环酸纤溶酶原链激酶激活剂复合物治疗并发血管炎
Br Heart J. 1988 Oct;60(4):361. doi: 10.1136/hrt.60.4.361.
3
Multicenter reperfusion trial of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) in acute myocardial infarction: controlled comparison with intracoronary streptokinase.急性心肌梗死静脉注射茴香酰化纤溶酶原链激酶激活剂复合物（APSAC）的多中心再灌注试验：与冠状动脉内链激酶的对照比较
J Am Coll Cardiol. 1988 Jun;11(6):1153-63. doi: 10.1016/0735-1097(88)90276-8.
4
Safety and side effects of anisoylated plasminogen streptokinase activator complex and streptokinase in patients with acute myocardial infarction. Interim report of the IRS II Study.茴香酰化纤溶酶原链激酶激活剂复合物与链激酶在急性心肌梗死患者中的安全性及副作用。IRS II研究中期报告。
Drugs. 1987;33 Suppl 3:282-5. doi: 10.2165/00003495-198700333-00053.
5
Safety and tolerance data from the Belgian multicentre study of anisoylated plasminogen streptokinase activator complex versus heparin in acute myocardial infarction.比利时多中心研究对比急性心肌梗死中茴香酰化纤溶酶原链激酶激活剂复合物与肝素的安全性和耐受性数据。
Drugs. 1987;33 Suppl 3:287-92. doi: 10.2165/00003495-198700333-00055.
6
Rash after treatment with anistreplase.使用茴香酰化纤溶酶原链激酶激活剂复合物治疗后出现皮疹。
Br Heart J. 1990 Oct;64(4):289-90. doi: 10.1136/hrt.64.4.289.
7
An interim report of the efficacy and safety of anisoylated plasminogen streptokinase activator complex (APSAC).茴香酰化纤溶酶原链激酶激活剂复合物（APSAC）疗效与安全性的中期报告。
Drugs. 1987;33 Suppl 3:298-311. doi: 10.2165/00003495-198700333-00058.
8
Anisoylated plasminogen streptokinase activator complex versus placebo. A preliminary multicentre study of safety and early mortality in acute myocardial infarction.茴香酰化纤溶酶原链激酶激活剂复合物与安慰剂对比：急性心肌梗死安全性及早期死亡率的初步多中心研究
Drugs. 1987;33 Suppl 3:261-7. doi: 10.2165/00003495-198700333-00048.
9
Tolerance and complications in a multicenter trial of intravenous APSAC and intracoronary streptokinase in acute myocardial infarction.
Clin Cardiol. 1990 Mar;Suppl 5:V11-4; discussion V27-32. doi: 10.1002/clc.4960131304.
10
Comparison of intravenous anisoylated plasminogen streptokinase activator complex and intracoronary streptokinase in acute myocardial infarction.急性心肌梗死中静脉注射茴香酰化纤溶酶原链激酶激活剂复合物与冠状动脉内注射链激酶的比较。
Am J Cardiol. 1988 Jul 1;62(1):25-30. doi: 10.1016/0002-9149(88)91359-8.
引用本文的文献
1
The first case of Henoch-Schonlein purpura associated with rosuvastatin: colonic involvement coexisting with small intestine.首例与瑞舒伐他汀相关的过敏性紫癜：结肠受累与小肠并存。
BMJ Case Rep. 2014 Mar 19;2014:bcr2013202644. doi: 10.1136/bcr-2013-202644.
2
A new skin lesion associated with intravenous streptokinase.一种与静脉注射链激酶相关的新皮肤损害。
BMJ. 1993 Apr 10;306(6883):973. doi: 10.1136/bmj.306.6883.973-b.
3
Iritis after treatment with streptokinase.链激酶治疗后发生的虹膜炎。
BMJ. 1994 Jul 9;309(6947):97. doi: 10.1136/bmj.309.6947.97b.
4
Multiple microemboli after disintegration of clot during thrombolysis for acute myocardial infarction.急性心肌梗死溶栓治疗期间血栓溶解后出现多个微栓子。
BMJ. 1989 Nov 25;299(6711):1310-2. doi: 10.1136/bmj.299.6711.1310.
5
Rash after treatment with anistreplase.使用茴香酰化纤溶酶原链激酶激活剂复合物治疗后出现皮疹。
Br Heart J. 1990 Oct;64(4):289-90. doi: 10.1136/hrt.64.4.289.
6
Safety and efficacy of repeat thrombolytic treatment after acute myocardial infarction.急性心肌梗死后重复溶栓治疗的安全性和有效性。
Br Heart J. 1990 Sep;64(3):177-81. doi: 10.1136/hrt.64.3.177.
7
Recurrence of a reactive arthritis following streptokinase therapy.链激酶治疗后反应性关节炎复发。
Postgrad Med J. 1991 Apr;67(786):402. doi: 10.1136/pgmj.67.786.402.
本文引用的文献
1
Serum sickness following streptokinase therapy.链激酶治疗后的血清病
AJR Am J Roentgenol. 1982 Jan;138(1):143-4. doi: 10.2214/ajr.138.1.143.
2
Intravenous streptokinase in evolving acute myocardial infarction.
Am J Cardiol. 1984 May 1;53(9):1209-16. doi: 10.1016/0002-9149(84)90066-3.
3
Serum sickness complicating intravenous streptokinase therapy in acute myocardial infarction.急性心肌梗死静脉注射链激酶治疗并发血清病
Eur Heart J. 1984 Dec;5(12):1010-2. doi: 10.1093/oxfordjournals.eurheartj.a061602.
4
Intravenous versus intracoronary streptokinase in acute myocardial infarction.
Am J Cardiol. 1985 Feb 1;55(4):309-12. doi: 10.1016/0002-9149(85)90366-2.
5
Serum sickness-like illness and leukocytoclastic vasculitis following intracoronary arterial streptokinase.冠状动脉内注射链激酶后发生的血清病样疾病和白细胞破碎性血管炎。
Am Heart J. 1987 Feb;113(2 Pt 1):395-7. doi: 10.1016/0002-8703(87)90287-0.
6
Crescentic glomerulonephritis: a possible complication of streptokinase treatment for myocardial infarction.新月体性肾小球肾炎：心肌梗死溶栓治疗的一种可能并发症。
Br Heart J. 1986 Nov;56(5):483-5. doi: 10.1136/hrt.56.5.483.
7
Leukocytoclastic vasculitis.
Arch Dermatol. 1976 Feb;112(2):219-26.
Zotero 插件